Cargando…

Intracranial Hypertension in Children without Papilledema

Researchers at Nationwide Children's Hospital studied the frequency of intracranial hypertension without papilledema in children followed in a multispecialty pediatric intracranial hypertension clinic.

Detalles Bibliográficos
Autores principales:	Chelse, Ana B., Epstein, Leon G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pediatric Neurology Briefs Publishers 2015
Materias:	Headache Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747132/ https://www.ncbi.nlm.nih.gov/pubmed/26933598 http://dx.doi.org/10.15844/pedneurbriefs-29-8-4

Ejemplares similares

Blunt Head Trauma and Headache
por: Chelse, Ana B., et al.
Publicado: (2015)

Cyclic AMP Accumulation in Migraine Induction
por: Chelse, Ana B., et al.
Publicado: (2015)

Pediatric Intracranial Hypertension
por: Sivaswamy, Lalitha
Publicado: (2016)

Update on Idiopathic Intracranial Hypertension Management
por: Souza, Marcio Nattan Portes, et al.
Publicado: (2022)

Acute Treatment Regimens for Migraine in the ED
por: Millichap, J. Gordon
Publicado: (2015)

Review of Prevention for Pediatric and Adolescent Migraine
por: Qubty, William, et al.
Publicado: (2016)

Migraine, Celiac Disease and Intestinal Microbiota
por: Rahmoune, Hakim, et al.
Publicado: (2017)

First‐line steroid treatment for spontaneous intracranial hypotension
por: Tonello, Simone, et al.
Publicado: (2022)

Autoimmune Post-Herpes Simplex Encephalitis
por: Chelse, Ana B., et al.
Publicado: (2016)

Idiopathic Intracranial Hypertension Without Papilledema (IIHWOP) in Chronic Refractory Headache
por: Favoni, Valentina, et al.
Publicado: (2018)

Cold extremities in migraine: a marker for vascular dysfunction in women
por: Linstra, K. M., et al.
Publicado: (2020)

Acute Migraine Therapy: New Drugs and New Approaches
por: Monteith, Teshamae S., et al.
Publicado: (2010)

Headache as an acute and post‐COVID‐19 symptom in COVID‐19 survivors: A meta‐analysis of the current literature
por: Fernández‐de‐las‐Peñas, César, et al.
Publicado: (2021)

Chronic migraine: Genetics or environment?
por: Chalmer, Mona Ameri, et al.
Publicado: (2021)

Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial
por: Ashina, Messoud, et al.
Publicado: (2021)

Headaches and obesity
por: Fortini, Ida, et al.
Publicado: (2022)

Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?
por: Simioni, Caio Vinicius de Meira Grava
Publicado: (2022)

Vestibular migraine
por: Silva, Viviane Passarelli Ramin, et al.
Publicado: (2022)

It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine
por: Kubota, Gabriel Taricani
Publicado: (2022)

Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real‐world evidence
por: Khalil, Modar, et al.
Publicado: (2022)

Multinational descriptive analysis of the real‐world burden of headache using the Migraine Buddy application
por: Goadsby, Peter J., et al.
Publicado: (2021)

Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study
por: de Vries Lentsch, Simone, et al.
Publicado: (2021)

Clinic and genetic predictors in response to erenumab
por: Zecca, Chiara, et al.
Publicado: (2022)

Behavioural intervention in medication overuse headache: A concealed double‐blind randomized controlled trial
por: Pijpers, Judith A., et al.
Publicado: (2022)

Functional connectivity changes in complex migraine aura: beyond the visual network
por: Silvestro, Marcello, et al.
Publicado: (2021)

Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy: The multicenter prospective cohort GARLIT study
por: Vernieri, Fabrizio, et al.
Publicado: (2022)

Commentary: Idiopathic Intracranial Hypertension Without Papilledema (IIHWOP) in Chronic Refractory Headache
por: De Simone, Roberto, et al.
Publicado: (2019)

P027. Idiopathic intracranial hypertension without papilledema in refractory chronic daily headache
por: Favoni, Valentina, et al.
Publicado: (2015)

Structural Connectivity in Gilles de la Tourette Syndrome
por: Chelse, Ana B., et al.
Publicado: (2015)

Trigeminal Neuralgia Due to Meckel's Cave Crowding in the Setting of Possible Idiopathic Intracranial Hypertension without Papilledema
por: Panda, Ananya, et al.
Publicado: (2021)

Neurofilament light chain marks severity of papilledema in idiopathic intracranial hypertension
por: Knoche, Theresia, et al.
Publicado: (2023)

Neuro-Behcet’s disease in a case with papilledema and intracranial hypertension as the initial presentation
por: Kurna, Sevda Aydin, et al.
Publicado: (2018)

Clinical and demographic differences between idiopathic intracranial hypertension patients with mild and severe papilledema
por: Micieli, Jonathan A., et al.
Publicado: (2020)

Headache due to Bilateral Subacute Subdural Hematomas following Intracranial Hypotension Caused by Cervical Disc Herniation
por: Steenstraten, Iris, et al.
Publicado: (2021)

Idiopathic Intracranial Hypertension in a Prepubertal Pediatric Japanese Patient Complicated by Severe Papilledema
por: Oka, Akiko, et al.
Publicado: (2016)

Anterior ischemic optic neuropathy in a patient with papilledema from idiopathic intracranial hypertension
por: Ma, Jingyi, et al.
Publicado: (2020)

Neurophysiological approach to central pain modulation in primary headaches
por: Rossi, P., et al.
Publicado: (2005)

Sensitivity of Papilledema as a Sign of Increased Intracranial Pressure
por: Krahulik, David, et al.
Publicado: (2023)

Optimizing resilience in orofacial pain: a randomized controlled pilot study on hope
por: Bartley, Emily J., et al.
Publicado: (2019)

Habituation of single CO(2) laser–evoked responses during interictal phase of migraine
por: de Tommaso, M., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_srv6jmtifbsvlfugr6p4gd1ira